Skip to Main content Skip to Navigation
Journal articles

In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.

Abstract : PURPOSE OF THE STUDY: The aim of this study was to evaluate the in vitro activity of tigecycline and other comparator agents against bacterial strains isolated from diabetic foot infections (DFI). PATIENTS AND METHODS: All diabetic patients hospitalized for a first episode of DFI (stage 2 to 4, according to the International Working Group of Diabetic Foot classification) were selected in N?s University hospital between January 2005 and June 2006. MICs were determined using custom broth microdilution panels against bacterial strains isolated from foot samples. RESULTS: Three hundred fifteen strains were studied. Tigecycline was active against 83.7% of all the strains especially Gram-positive cocci (97.3%) in particular methicillin-resistant Staphylococcus aureus (96%), Enterobacteriaceae (88.5%) and anaerobes (100%). Exclusively Pseudomonas aeruginosa and Proteae were not covered by this antibiotic. CONCLUSIONS: Tigecycline, a new broad spectrum antimicrobial agent, is qualified to belong to the therapeutic arsenal package of complicated skin and soft tissue infections in diabetic patients after microbial documentation.
Document type :
Journal articles
Complete list of metadatas

Cited literature [12 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00258566
Contributor : Jean-Philippe Lavigne <>
Submitted on : Friday, February 22, 2008 - 3:34:20 PM
Last modification on : Friday, June 12, 2020 - 5:00:11 PM
Long-term archiving on: : Friday, November 25, 2016 - 9:35:22 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Albert Sotto, Nicole Bouziges, Nathalie Jourdan, Jean-Louis Richard, Jean-Philippe Lavigne. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.. Pathologie Biologie, Elsevier Masson, 2007, 55 (8-9), pp.398-406. ⟨10.1016/j.patbio.2007.07.003⟩. ⟨inserm-00258566⟩

Share

Metrics

Record views

141